New York, NY -- (SBWIRE) -- 03/19/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Sarepta Therapeutics, Inc. (NASDAQ:SRPT) and Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP).
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) a biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics for the treatment of serious and life-threatening rare and infectious diseases is currently up (+1.57%) on 1,140,738 shares traded after Deutsche Bank biotech analyst Robyn Karnauskas picks up coverage of Sarepta Therapeutics today with a buy rating. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is currently up (+958.79%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) a pharmaceutical company that focuses on the discovery, development, and commercialization of drugs based on prostones and other novel drug technologies in the Americas, Europe, and Asia is currently up (+5.02%) on 210,414 shares traded after SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K/A, Results of Operations and Financial Condition, Regulation FD Disclosure. Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) is currently up (+53.44%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Contact Info:
Growing Stock Report
editor@GrowingStockReport.com
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)